S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
USOTC
Hikma Pharmaceuticals plc (PK) (HKMPY)
Hikma Pharmaceuticals plc (PK) (HKMPY) Financials

Hikma Pharmaceuticals plc (PK) (HKMPY)

51.4825

0.00

(0.00%)

Closed November 28 3:00PM

Delayed by 15 minutes

Hikma Pharmaceuticals plc (PK) Financial Summary

The current HKMPY market cap is 5.71B. The company's latest EPS is USD 1.7306 and P/E is 11.22.

Income Statement

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	2.21B	2.34B	2.55B	2.52B	2.88B
Operating Income	482M	613M	620M	287M	399M
Net Income	486M	431M	421M	188M	192M

Balance Sheet

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	3.93B	4.14B	4.37B	4.47B	4.68B
Total Liabilities	1.8B	1.99B	1.91B	2.32B	2.47B
Total Equity	2.13B	2.15B	2.47B	2.15B	2.21B

Cash Flow

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	472M	464M	638M	530M	608M
Investing	-151M	-283M	-238M	-607M	-333M
Financing	-155M	-298M	-287M	-58M	-337M

Stats and Ratios

Market Cap	5.71B
Price to Earnings Ratio	11.22
Price to Sales Ratio	0.75
Price to Cash Ratio	10.51
Price to Book Ratio	0.98
Dividend Yield	2.99%

Share Statistics

Shares Outstanding	110.94M
Average Volume (1 week)	1.08k
Average Volume (1 Month)	586
52 Week Change	18.38%
52 Week High	55.56
52 Week Low	42.51
Spread (Intraday)	5.52 (10.4%)

Company Info

Company Name	Hikma Pharmaceuticals plc (PK)
Address	1 new burlington place london W1S 2HR
Website	https://www.hikma.com
Industry	pharmaceutical preparations (2834)

Hikma Pharmaceuticals (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions